|Articles|March 11, 2009
Bevacizumab for neovascular glaucoma
Intracameral Bevacizumab (Avastin) for Neovascular Glaucoma: A Pilot Study in 6 Patients
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement












































